English | Español
Amanda Rupp | Sep 8, 2016

FDA orders label changes to stress perils of mixing opioids, benzodiazepines
+ Technology/Innovation
Amanda Rupp | Sep 7, 2016

NIH funds teams to find biological factors of neural regeneration
+ Technology/Innovation
Amanda Rupp | Sep 7, 2016

FDA approves clot retrieval devices for stroke treatment
+ Technology/Innovation
Amanda Rupp | Sep 7, 2016

NIH researchers find extreme temperatures may heighten preterm birth risk
+ Regulatory
Amanda Rupp | Sep 7, 2016

Heart association's obesity report outlines fight that lies ahead
+ Technology/Innovation
Amanda Rupp | Sep 7, 2016

NIH review discovers nondrug approaches to treat common pain
+ Regulatory
John Breslin | Sep 7, 2016

Florida governor criticizes D.C. response to state's Zika virus outbreak
+ Technology/Innovation
Amanda Rupp | Sep 6, 2016

FDA encourages Zika virus tests for all donated blood in U.S.

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes